Formative research in clinical trial development: Attitudes of patients with arthritis in enhancing prevention trials

Annals of the Rheumatic Diseases

Volumn 66, Issue 4, 2007, Pages 542-544

  Taylor, Holly A ^a   Sugarman, Jeremy ^a   Pisetsky, David S ^b   Bathon, Joan ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATIENT ATTITUDE; PATIENT SELECTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; DISEASE PROGRESSION; FEMALE; HUMANS; INFORMED CONSENT; INTERVIEWS; MALE; MIDDLE AGED; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; REFUSAL TO PARTICIPATE; RESEARCH DESIGN;

EID: 34147213973     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.059600     Document Type: Article

References (15)

1. Shadish WR, Cook TD, Leviton LC. Foundations of program evaluation: theories of practice. Newbury Park: Sage, 1991.
2. Rossi PH, Lisep MW, Freeman HE. Evaluation: a systematic approach. 7th edn Thousand Oaks: Sage, 2004.
3. MacQueen K, Sugarman J, on behalf of the HIV Prevention Trials Network Ethics Working Group. HIV Prevention Trials Network: ethics guidance for research. 2003. http://www.hptn.org/Web%20Documents/EWG/ HPTNEthicsGuidanceFINAL15April2003.pdf (accessed 28 Dec 2006).
4. Geletka R, St Clair EW. Treatment of early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:791-809.
5. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 2003;48:1771-4.
6. Smolen JS, Aletaha D, Machold KP. Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005;19:163- 77.
7. Aletaha D, Breedveld FC, Smolen JS. The need for new classification criteria for rheumatoid arthritis. Arthritis Rheum 2005;52:3333-6.
8. Kim JM, Weiisman MH. When does rheumatoid arthritis begin and why do we need to know? Arthritis Rheum 2000;43:473-84.
9. Machold KP, Stamm TA, Eberl GJ, Nell VKP, Dunky A, Uffmann M, et al. Very recent onset arthritis-clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002;29:2278-87.
10. Machold KP, Nell VKP, Stamm TA, Eberl G, Steiner G, Smolen JS, et al. The Austrian Early Arthritis Registry. Clin Exp Rheumatol 2003;21:S113-17.
11. Symmons DPM, Silman AJ. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 2003;21:S94-9.
12. Van Aken J, Lard LR, Le Cessie S, Hazes JMW, Breedveld FC, Huizinga TWJ, et al. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:274-9.
13. Mattson ME, Curb JD, McCardle R. Participation in a clinical trial: the patient's point of view. Control Clin Trials 1985;6:156-67.
14. Gorkin L, Schron EB, Handshaw K, Shea S, Kinney MR, Branyon M, et al. Clinical trial enrollers vs. nonernollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project, Control Clin Trials 1996;17:46-59.
15. Schron EB, Wassertheil-Smoller S, Pressel S. Clinical trial participant satisfaction: urvey of SHEP enrollees. J Am Geriatr Soc 1997;45:934-8.